Sep. 19, 2019—Advances in genetics are leading to new ways to treat cardiomyopathies — devastating heart muscle disorders that lead to heart failure.
Sep. 9, 2019—Vanderbilt's Master’s Program in Biomedical Sciences prepares students for a broad array of health professional careers.
Sep. 5, 2019—A team led by a neurosurgeon-scientist and an engineering professor who specializes in techniques for analyzing functional neuroimaging data has received a $3 million grant to study disturbances in brain networks related to attention lapses and cognitive deficits in patients with temporal lobe epilepsy.
Sep. 5, 2019—According to a new study, the tiny zebrafish may hold the secret to regenerating damaged retinas in humans.
Sep. 4, 2019—A novel treatment for Prader-Willi syndrome, one of the most common genetic causes of obesity, may improve the insatiable hunger that patients with the disorder experience.
Sep. 4, 2019—Researchers at Vanderbilt University Medical Center are partnering with the Dutch biopharmaceutical firm Batavia Biosciences and Nashville-based IDBiologics to bring to the clinic a highly potent Zika virus neutralizing antibody they isolated three years ago.
Aug. 26, 2019—Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI).
Aug. 22, 2019—Researchers have made a paradigm-shifting discovery that could lead to new treatments, better health and longer life for patients with Type 1 diabetes.
Aug. 15, 2019—A study led by Anna Vilgelm, MD, PhD, and Ann Richmond, PhD, has identified a possible second-line treatment for melanoma patients.
Aug. 15, 2019—Investigators are exploring the molecular mechanisms behind the association of chronic inflammation and colon cancer.